DRUG DESIGN DEVELOPMENT AND THERAPY, cilt.7, ss.19-24, 2013 (SCI-Expanded)
Background: The purpose of this study was to investigate the effect of intraperitoneal ghrelin on vitreous levels of interleukin (IL)-1, IL-6, and tumor necrosis factor-alpha (TNF-alpha) and to compare its effects with those of intraperitoneal infliximab in an experimental uveitis model.